Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
NCT01188746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2020-02-06
Summary
The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by cancer, also called malignancy.
All people who participate in this study have ascites associated with cancer. Ascites can cause symptoms that make it difficult for the patient to do simple things. Patients with ascites often report:
Abdominal swelling Difficulty walking. Difficulty breathing. Feeling full when eating. Clothes not fitting due to a swollen abdomen. Swelling in the legs. It is hoped that this catheter will relieve the symptoms of the ascites. The goal of the investigators study is to understand the quality of life before the procedure and after the procedure. Since the patient is having this procedure to make their symptoms better, the investigators want to hear from the patient of how the procedure has affected their quality of life.
Conditions
- Ascites
Interventions
- BEHAVIORAL
-
McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
Participants will be interviewed twice (if they chose to participate in the qualitative portion) and complete instruments at three time points: 1) immediately prior to the procedure, 2)within seven days after the procedure, preferably prior to discharge, and 3) three weeks after their catheter placement.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Piera Robson, RN · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2020-02-29
- Completion
- 2020-02-29
Countries
- United States
Study Locations
More Related Trials
-
The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis
NCT01777971 ·Status: WITHDRAWN
-
Evaluation of 'Melody' Paracentesis Device for Ascites Therapy
NCT03191851 ·Status: COMPLETED ·Phase: NA
-
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
NCT05014594 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
NCT00603200 ·Status: WITHDRAWN
-
Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
NCT06319547 ·Status: RECRUITING ·Phase: NA
-
Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites
NCT04569565 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites
NCT03200106 ·Status: COMPLETED
-
A Clinical Study of Portal Vein Embolization and Liver Venous Deprivation
NCT05457374 ·Status: UNKNOWN ·Phase: NA
-
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
NCT03027635 ·Status: TERMINATED ·Phase: NA
-
LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease
NCT04953143 ·Status: COMPLETED ·Phase: NA
-
To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.
NCT02467322 ·Status: COMPLETED ·Phase: NA
-
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites
NCT02400164 ·Status: COMPLETED ·Phase: NA
-
Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
NCT02467348 ·Status: COMPLETED ·Phase: NA
-
Body Composition Analysis in Cirrhotic Undergoing Paracentesis
NCT02022150 ·Status: UNKNOWN
-
Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites
NCT01854125 ·Status: UNKNOWN ·Phase: PHASE3
-
Albumin for Hepatocellular Carcinoma
NCT03974074 ·Status: UNKNOWN ·Phase: PHASE3
-
Improving Performance of Paracentesis in Medical Residency Training
NCT01403987 ·Status: COMPLETED ·Phase: NA
-
ALFApump System Versus Standard of Care in Ascites Treatment
NCT01528410 ·Status: COMPLETED ·Phase: PHASE3
-
High Dose Albumin in Refractory Ascites
NCT05867602 ·Status: RECRUITING ·Phase: PHASE2
-
To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites
NCT02649335 ·Status: COMPLETED ·Phase: PHASE3
-
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
NCT05998330 ·Status: RECRUITING ·Phase: NA
-
Portal Venous Hemodynamic Changes After Hepatectomy
NCT01073345 ·Status: UNKNOWN
-
Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics
NCT02818673 ·Status: UNKNOWN ·Phase: PHASE3
-
An Integrative Model for Palliative Care in End-Stage Liver Disease
NCT05238779 ·Status: COMPLETED
-
Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
NCT05057572 ·Status: COMPLETED ·Phase: NA